Psychedelics Investing NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression 30 October
Psychedelics Investing Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 28 October
